{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:45:41Z","timestamp":1772905541843,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013532","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000}}],"reference-count":125,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013532.pub2","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T01:51:06Z","timestamp":1686189066000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Granulocyte colony-stimulating factor with or without stem or progenitor cell\u00a0or growth factors infusion for people with compensated or decompensated advanced chronic liver disease"],"prefix":"10.1002","volume":"2023","author":[{"given":"Agostino","family":"Colli","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine and Haematology; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Fraquelli","sequence":"additional","affiliation":[{"name":"Gastroenterology and Endoscopy Unit; Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Prati","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine and Haematology; Ospedale Alessandro Manzoni; Lecco Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Casazza","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health; Universit\u00e0 degli Studi di Milano; Milan Italy"},{"name":"Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"10.1002\/14651858.CD013532.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cgh.2020.02.022","article-title":"Multiple cycles of granulocyte colony-stimulating factor increase survival times of patients with decompensated cirrhosis in a randomized trial","volume":"19","author":"De","year":"2021","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"7","key":"10.1002\/14651858.CD013532.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3748\/wjg.v19.i7.1104","article-title":"Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure","volume":"19","author":"Duan","year":"2013","journal-title":"World Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD013532.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jhep.2021.07.033","article-title":"Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: a multicenter randomized trial (GRAFT study)","volume":"75","author":"Engelmann","year":"2021","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013532.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"Garg","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013532.pub2-BIB0005|cit5","first-page":"64","article-title":"Effect of granulocyte colony-stimulating factor and erythropoietin on patients with acute-on-chronic liver failure","volume":"10","author":"Haque","year":"2020","journal-title":"Euroasian Journal of Hepato-Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD013532.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis","volume":"148","author":"Kedarisetty","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/S0168-8278(22)00663-8","article-title":"A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis","volume":"77","author":"Morgan","year":"2022","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","article-title":"Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial","volume":"3","author":"Newsome","year":"2018","journal-title":"Lancet. Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MEG.0000000000000801","article-title":"Granulocyte colony-stimulating factor improves survival of patients with decompensated cirrhosis: a randomized-controlled trial","volume":"29","author":"Prajapati","year":"2017","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD013532.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12072-017-9814-1","article-title":"APASL ACLF working party. Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage","volume":"11","author":"Saha","year":"2017","journal-title":"Hepatology International"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0011|cit11","first-page":"A17","article-title":"Effect of granulocyte colony-stimulating factor (G-CSF) on mortality and complications viz. sepsis, encephalopathy, hepatorenal syndrome, and gastrointestinal bleed in severe alcoholic hepatitis: a randomized controlled study","volume":"5","author":"Sharma","year":"2017","journal-title":"United European Gastroenterology Journal"},{"issue":"3","key":"10.1002\/14651858.CD013532.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.30516","article-title":"Efficacy of granulocyte colony-stimulating factor in the management of steroid-nonresponsive severe alcoholic hepatitis: a double-blind randomized controlled trial","volume":"70","author":"Shasthry","year":"2019","journal-title":"Hepatology"},{"issue":"9","key":"10.1002\/14651858.CD013532.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"Singh","year":"2014","journal-title":"American Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD013532.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cgh.2018.01.040","article-title":"Efficacy of granulocyte colony-stimulating factor and n-acetylcysteine therapies in patients with severe alcoholic hepatitis","volume":"16","author":"Singh","year":"2018","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0015|cit15","first-page":"215A","article-title":"Granulocyte-colony stimulating factor (G-CSF) with or without four weeks of n-acetyl cysteine (NAC) in severe alcoholic hepatitis","volume":"Suppl 1","author":"Singh","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"e53719","DOI":"10.1371\/journal.pone.0053719","article-title":"Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial","volume":"8","author":"Spahr","year":"2013","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"885829","DOI":"10.3389\/fimmu.2022.885829","article-title":"Granulocyte colony-stimulating factor accelerates the recovery of hepatitis B virus-related acute-on-chronic liver failure by promoting M2-like transition of monocytes","volume":"13","author":"Tong","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10.1002\/14651858.CD013532.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s12072-022-10314-x","article-title":"Multiple cycles of granulocyte colony-stimulating factor in decompensated cirrhosis: a double-blind RCT","volume":"16","author":"Venkitaraman","year":"2022","journal-title":"Hepatology International"},{"issue":"4","key":"10.1002\/14651858.CD013532.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.29763","article-title":"Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: a randomized trial","volume":"68","author":"Verma","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD013532.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/MEG.0b013e3283488b00","article-title":"Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells","volume":"23","author":"Amer","year":"2011","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/liv.13923","article-title":"Early cirrhosis and a preserved bone marrow niche favour regenerative response to growth factors in decompensated cirrhosis","volume":"39","author":"Anand","year":"2019","journal-title":"Liver International"},{"issue":"3","key":"10.1002\/14651858.CD013532.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s12015-011-9322-y","article-title":"Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis","volume":"8","author":"El-Ansary","year":"2012","journal-title":"Stem Cell Reviews and Reports"},{"issue":"3","key":"10.1002\/14651858.CD013532.pub2-BIB0024|cit24","first-page":"268","article-title":"Autologous bone marrow stem cell transplantation in liver cirrhosis after correcting nutritional anomalies, a controlled clinical study","volume":"21","author":"Esmaeilzadeh","year":"2019","journal-title":"Cell Journal"},{"issue":"2","key":"10.1002\/14651858.CD013532.pub2-BIB0025|cit25","first-page":"433","article-title":"Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease","volume":"9","author":"Fiuza","year":"2002","journal-title":"Clinical And Diagnostic Laboratory Immunology"},{"issue":"4","key":"10.1002\/14651858.CD013532.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12072-013-9473-9","article-title":"Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluation","volume":"7","author":"Gaia","year":"2013","journal-title":"Hepatology International"},{"issue":"10","key":"10.1002\/14651858.CD013532.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","article-title":"Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial","volume":"21","author":"Kharaziha","year":"2009","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MEG.0b013e32832eb69a","article-title":"Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study","volume":"22","author":"Lyra","year":"2010","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5966\/sctm.2015-0004","article-title":"Intraportal infusion of bone marrow mononuclear or cd133+ cells in patients with decompensated cirrhosis: a double-blind randomized controlled trial","volume":"5","author":"Mohamadnejad","year":"2016","journal-title":"Stem Cells Translational Medicine"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jceh.2019.05.003","article-title":"Granulocyte colony-stimulating factor use in decompensated cirrhosis: lack of survival benefit","volume":"10","author":"Philips","year":"2020","journal-title":"Journal of Clinical and Experimental Hepatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013532.pub2-BIB0031|cit31","first-page":"S26","article-title":"Comparison of imipenem and tigecycline versus imipenem, tigecycline combined with GM-CSF in patients with spontaneous bacterial peritonitis and septic shock","volume":"12","author":"Ranjan","year":"2022","journal-title":"Journal of Clinical and Experimental Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD013532.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00795-005-0298-z","article-title":"Development of cell therapy using autologous bone marrow cells for liver cirrhosis","volume":"38","author":"Sakaida","year":"2005","journal-title":"Medical Molecular Morphology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3727\/096368910X514314","article-title":"Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases","volume":"19","author":"Salama","year":"2010","journal-title":"Cell Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD013532.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15406\/jlrdt.2016.02.00039","article-title":"Exciting results with injection darbepoietin alfa and pegfilgrastim in patients with decompensated liver cirrhosis","volume":"2","author":"Sharma","year":"2016","journal-title":"Journal of Liver Research, Disorders & Therapy"},{"issue":"2","key":"10.1002\/14651858.CD013532.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbmt.2017.10.026","article-title":"Granulocyte colony-stimulating factor use after autologous peripheral blood stem cell transplantation: comparison of two practices","volume":"24","author":"Singh","year":"2018","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD013532.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1634\/stemcells.2005-0542","article-title":"Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy","volume":"24","author":"Terai","year":"2006","journal-title":"Stem Cells"},{"issue":"121","key":"10.1002\/14651858.CD013532.pub2-BIB0037|cit37","first-page":"170","article-title":"Mechanism and efficacy of mobilization of granulocyte colony-stimulating factor in the treatment of chronic hepatic failure","volume":"60","author":"Xing","year":"2013","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.exphem.2004.09.005","article-title":"G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs","volume":"33","author":"Yannaki","year":"2005","journal-title":"Experimental Hematology"},{"issue":"5","key":"10.1002\/14651858.CD013532.pub2-BIB0039|cit39","first-page":"279","article-title":"Randomised controlled clinical study of granulocyte colony-stimulating factor in the treatment of chronic hepatitis B-related acute liver failure","volume":"29","author":"Xu","year":"2016","journal-title":"Infectious Diseases Information"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0040|cit40","first-page":"521","article-title":"The clinical trial of G-CSF for end-stage alcoholic liver disease","volume":"25","author":"Zhou","year":"2020","journal-title":"Chinese Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s13063-018-3092-7","article-title":"Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial","volume":"19","author":"Cho","year":"2018","journal-title":"Trials"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/35018642","article-title":"Hepatocytes from non-hepatic adult stem cells","volume":"406","author":"Alison","year":"2000","journal-title":"Nature"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2016.10.012","article-title":"Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis","volume":"66","author":"Arroyo","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"22","key":"10.1002\/14651858.CD013532.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013532.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"110","key":"10.1002\/14651858.CD013532.pub2-BIB0046|cit46","first-page":"1","article-title":"Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis","volume":"7","author":"Castellini","year":"2018","journal-title":"Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD013532.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1665-2681(19)30757-4","article-title":"Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis","volume":"14","author":"Chavez-Tapia","year":"2015","journal-title":"Annals of Hepatology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0048|cit48","volume-title":"Statistical Power Analysis in the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D'Amico","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"Franchis","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0052|cit52","doi-asserted-by":"crossref","unstructured":"Deeks JJ Higgins JP Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch10"},{"issue":"3","key":"10.1002\/14651858.CD013532.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013532.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bbmt.2014.05.003","article-title":"Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","volume":"20","author":"Duong","year":"2014","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD013532.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013532.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0041-1723034","article-title":"The current status of granulocyte-colony stimulating factor to treat acute-on-chronic liver failure","volume":"41","author":"Engelmann","year":"2021","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jhep.2011.06.022","article-title":"New horizons for stem cell therapy in liver disease","volume":"56","author":"Forbes","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrgastro.2016.97","article-title":"Liver regeneration - mechanisms and models to clinical application","volume":"13","author":"Forbes","year":"2016","journal-title":"Nature Reviews. Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013532.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.2005.069153","article-title":"Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study","volume":"55","author":"Foucher","year":"2006","journal-title":"Gut"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejim.2016.03.020","article-title":"Evidence-based clinical practice: overview of threats to the validity of evidence and how to minimise them","volume":"32","author":"Garattini","year":"2016","journal-title":"European Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","article-title":"Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis","volume":"51","author":"Garcia-Tsao","year":"2010","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jclinepi.2018.10.009","article-title":"Increased risks for random errors are common in outcomes graded as high certainty of evidence","volume":"106","author":"Gartlehner","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/lt.21965","article-title":"Bone marrow-derived stem cells in liver repair: 10 years down the line","volume":"16","author":"Gilchrist","year":"2010","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0065|cit65","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"4","key":"10.1002\/14651858.CD013532.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD013532.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD013532.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence--publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD013532.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines: 6. Rating the quality of evidence--imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD013532.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence--inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD013532.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence--indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD013532.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD013532.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD013532.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD013532.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing Summary of Findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD013532.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing Summary of Findings tables - continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD013532.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 15. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jclinepi.2017.05.005","article-title":"GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence","volume":"87","author":"Guyatt","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0081|cit81","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0082|cit82","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated August 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0083|cit83","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"784240","DOI":"10.3389\/fmed.2021.784240","article-title":"Therapeutic effect and safety of granulocyte colony-stimulating factor therapy for acute-on-chronic liver failure: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Hou","year":"2021","journal-title":"Frontiers in Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013532.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5144\/0256-4947.2021.383","article-title":"Effectiveness of granulocyte colony-stimulating factor for patients with acute-on-chronic liver failure: a meta-analysis","volume":"41","author":"Huang","year":"2021","journal-title":"Annals of Saudi Medicine"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0086|cit86","unstructured":"International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH) ICH Harmonised Guideline. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2) database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"e007700","DOI":"10.1136\/bmjopen-2015-007700","article-title":"REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial","volume":"5","author":"King","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013532.pub2-BIB0090|cit90","first-page":"1552","article-title":"Growth hormone stimulates proliferation of old-aged regenerating liver through forkhead box m1b","volume":"38","author":"Krupczak-Hollis","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S2468-1253(17)30359-X","article-title":"Haemopoietic stem cell therapy in cirrhosis: the end of the story?","volume":"3","author":"Lanthier","year":"2018","journal-title":"Lancet. Gastroenterology & Hepatology"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD013532.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.seminhematol.2004.09.004","article-title":"Preclinical and clinical studies: a preview of potential future applications of erythropoietic agents","volume":"41","author":"Lewis","year":"2004","journal-title":"Seminars in Hematology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0093|cit93","doi-asserted-by":"crossref","unstructured":"Li T Higgins JP Deeks JJ Chapter 5: Collecting data. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019 Available from training.cochrane.org\/handbook\/archive\/v6","DOI":"10.1002\/9781119536604"},{"issue":"2","key":"10.1002\/14651858.CD013532.pub2-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD013532.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"100139","DOI":"10.1016\/j.jhepr.2020.100139","article-title":"Granulocyte colony-stimulating factor for alcoholic hepatitis: a systematic review and meta-analysis of randomised controlled trials","volume":"2","author":"Marot","year":"2020","journal-title":"JHEP Reports"},{"issue":"9128","key":"10.1002\/14651858.CD013532.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/apt.12645","article-title":"Systematic review: the effects of autologous stem cell therapy for patients with liver disease","volume":"39","author":"Moore","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD013532.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.2013.13805","article-title":"The state of US health, 1990-2010: burden of diseases, injuries, and risk factors","volume":"310","author":"Murray","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD013532.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jclinepi.2013.02.004","article-title":"The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses","volume":"66","author":"Mustafa","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0100|cit100","unstructured":"Cirrhosis in over 16s: assessment and management www.nice.org.uk\/guidance\/ng50"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0101|cit101","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010542.pub2","article-title":"Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease","author":"Pavlov","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD013532.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0104|cit104","unstructured":"Review Manager 5 (RevMan 5) The Cochrane Collaboration 2020"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jus.2007.02.006","article-title":"Liver transplantation","volume":"10","author":"Rossi","year":"2007","journal-title":"Journal of Ultrasound"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000456580","article-title":"Lessons from epidemiology: the burden of liver disease","volume":"35","author":"Rowe","year":"2017","journal-title":"Digestive Diseases"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/sim.2971","article-title":"Arcsine test for publication bias in meta-analyses with binary outcomes","volume":"27","author":"R\u00fccker","year":"2008","journal-title":"Statistics in Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013532.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"35","key":"10.1002\/14651858.CD013532.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"5","key":"10.1002\/14651858.CD013532.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane reviews: the ROBES Meta-Epidemiologic Study","volume":"187","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD013532.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0112|cit112","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"3","key":"10.1002\/14651858.CD013532.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3855\/jidc.14961","article-title":"The effects of granulocyte-colony stimulating factor on chronic liver disease: a meta-analysis","volume":"16","author":"Shi","year":"2022","journal-title":"Journal of Infection in Developing Countries"},{"issue":"5","key":"10.1002\/14651858.CD013532.pub2-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012069.pub2","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents \u2013 assessment of adverse events in non-randomised studies","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/hep.24315","article-title":"Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration and function","volume":"53","author":"Thomas","year":"2011","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0116|cit116","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA); 2nd edition. Copenhagen Trial Unit, 2017 Available from ctu.dk\/tsa\/learn-more"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0117|cit117","unstructured":"TSA - Trial Sequential Analysis Copenhagen Trial Unit 2017"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1749\u201361","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.29864","article-title":"Reply","volume":"68","author":"Verma","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial Sequential Analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in a random-effects meta-analysis","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD013532.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD013532.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"366","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD013532.pub2-BIB0124|cit124","first-page":"90","article-title":"Effects of granulocyte colony-stimulating factor on patients with liver failure: a meta-analysis","volume":"4","author":"Yang","year":"2016","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD013532.pub2-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013532","article-title":"Granulocyte colony-stimulating factor with or without stem or progenitor cell infusion for people with compensated or decompensated advanced chronic liver disease","author":"Colli","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T12:48:28Z","timestamp":1735735708000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013532.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":125,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013532.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]}}}